Description
Spironolactone is indicated for the following:
• Essential hypertension.
• Short-term preoperative treatment of patients with primary hyperaldosteronism.
• Congestive heart failure (alone or in combination with standard therapy), including severe heart failure (NYHA class III-IV) to increase survival and reduce the risk of hospitalization when used in addition to standard therapy.
• Conditions in which primary aldosteronism may be present, including liver cirrhosis accompanied by edema and / or ascites, nephrotic syndrome and other edematous conditions (alone or in combination with standard therapy).
• Hypokalemia / hypomagnesemia induced by diuretics as concomitant treatment.
• Establishment of a diagnosis of primary hyperaldosteronism.
• Management of hirsutism.






Reviews
There are no reviews yet.